Doris-Ann Williams has been Chief Executive of BIVDA since October 2001. She has more than 35 years’ experience in the IVD sector. She has held a variety of roles, initially in R&D at Amersham International/Amerlite Diagnostics Ltd and subsequently in commercial roles internationally for Becton Dickinson, ICN and Hitachi Chemical Diagnostics. Doris-Ann also works closely with other global IVD industry associations and in the UK as part of Life Sciences UK. She was awarded an MBE in January 2011 and was recognised as a Friend of the Royal College of Pathologists in November 2012 and also as Friend of the Association for Clinical Biochemistry in July 2015. She is currently a Vice-President of the Parliamentary & Scientific Committee. She is also an active member of a number of Government and NHS steering groups & boards. During 2016, Doris-Ann was invited to attend the High-Level meeting on Antimicrobial Resistance at the United Nations General Assembly in New York (September) and was a member of the Precision Medicine delegation to India for the Prime Minister’s visit in November.
